Trader Note — 9846 total
BEAT heads into the aftermath of its Q1 2026 earnings print with one of the most striking short-covering runs seen in this name — and a coordinated insider buying cluster that telegraphed the move weeks in…
Chanson International Holding enters this week as one of the most extraordinary short-squeeze setups on Nasdaq — a micro-cap bakery operator whose stock has collapsed 99% in a month while short sellers scramble to…
DRMA enters the post-earnings session with a notable alignment: the CEO who spent $1 million buying shares in December is now watching the company he built beat Q1 estimates — and the short base that towered over the…
Enovix has delivered a rare piece of good news for bulls this week: shorts are retreating. That retreat, however, is happening against a backdrop that still looks hostile — a JP Morgan downgrade, a wall of short…
PATH heads into its May 27 earnings report with one of the most heavily shorted setups in the software sector — and the bears have been adding, not covering. Short interest has climbed to 27.1% of the free float, up…
Innoviz Technologies enters its Q1 2026 earnings call — scheduled for tomorrow, May 14 — with a 14% weekly gain on the stock and a Goldman Sachs downgrade hanging over the name simultaneously. The borrow market tells a…
Ouster heads into the week after its Q1 earnings release with a notable tension: the founder is consistently selling, a key analyst just downgraded, and shorts are quietly rebuilding their position — all while the…
UWM Holdings heads into the second week of May with a striking insider-selling streak that runs directly against a recovering short position — the two together telling a cautious story about sentiment at the top of the…
LGVN headed into its Q1 print already battered — and the numbers did little to stop the bleeding. The stock closed Tuesday at $0.75, down 10% on the day and 12% on the week. Over the past month it has shed 35%.…
Nuvation Bio heads into its May 21 investor event with an intriguing split — one of the most heavily shorted names in pharma is quietly unwinding its short position even as a freshly announced manufacturing deal…
Affirm Holdings enters the post-earnings window with a conflicting signal: the stock has surged 35% over the past month, yet shorts have quietly added to their positions through the rally rather than step aside. Short…
SEER reported Q1 2026 results after the close on May 13 — a revenue miss against a weak consensus, offset by reaffirmed full-year guidance. That combination keeps the stock at a crossroads: a tiny research-tools name…
Spruce Power delivered better-than-expected operational improvement in Q1 — but a going concern disclosure and a looming debt deadline have kept the stock pinned lower, with shares down 7.4% on the week to $3.11. The…
Leslie's just reported Q2 2026 results after Tuesday's close, and the print is a study in contradictions: revenue of $184.7M beat the $162.2M estimate by 14%, but adjusted EPS came in at -$5.36 against expectations of…
Motorsport Games reported Q1 2026 results on May 13 with the borrow market at maximum tightness, the stock up 46% in a month, and its largest shareholder quietly offloading shares into the rally. The most striking…
CXAI headed into its Q1 earnings release with one of the sharpest short-interest buildups of the year — and the results just landed, with the company topping both revenue and EPS estimates. Short sellers moved…
Palantir Technologies heads into the week of May 13 with a striking divergence: options traders are the most bullish they've been in months, yet short sellers have been quietly adding to positions at the fastest pace…
DYN posted a better-than-expected Q1 this week, and the 5.2% weekly gain shows investors noticed. The real question now is whether a narrowing loss and a fresh analyst nudge from Bernstein are enough to dent a short…
Adicet Bio just delivered a Q1 earnings beat — but the market's reaction this week captures the contradiction at the heart of this stock: a credible scientific narrative, a unanimous analyst buy consensus, and a price…
XPeng heads into a pivotal week with a blockbuster strategic headline competing for attention against a Q1 earnings print due May 28. The biggest story landed Wednesday evening. The Financial Times reported that XPeng…
